Evidence map›Paper›PMID 35997536›Full record

ArticleDevelopment (Cambridge, England)2022

PHLPP1 regulates CFTR activity and lumen expansion through AMPK.

Viola H Lobert, Maren L Skardal, Lene Malerød, Julia E Simensen, Hermine A Algra, Aram N Andersen, Thomas Fleischer, Hilde A Enserink, Knut Liestøl, Joan K Heath and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Viola H LobertDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0003-4225-6373
Maren L SkardalDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0002-5783-1695
Lene MalerødDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.
Julia E SimensenDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.
Hermine A AlgraDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0002-0940-9238
Aram N AndersenDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.
Thomas FleischerDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0003-0985-8460
Hilde A EnserinkDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0002-2750-4837
Knut LiestølDepartment of Informatics, University of Oslo, Oslo 0316, Norway.
Joan K HeathEpigenetics and Development Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0001-6955-232X
Tor Erik RustenDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0002-9150-2676
Harald A StenmarkDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo 0379, Norway.ORCID 0000-0002-1971-4252
Oslo University Hospital · NOUniversity of Oslo · NOWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex organ development depends on single lumen formation and its expansion during tubulogenesis. This can be achieved by correct mitotic spindle orientation during cell division, combined with luminal fluid filling that generates hydrostatic pressure. Using a human 3D cell culture model, we have identified two regulators of these processes. We find that pleckstrin homology leucine-rich repeat protein phosphatase (PHLPP) 2 regulates mitotic spindle orientation, and thereby midbody positioning and maintenance of a single lumen. Silencing the sole PHLPP family phosphatase in Drosophila melanogaster, phlpp, resulted in defective spindle orientation in Drosophila neuroblasts. Importantly, cystic fibrosis transmembrane conductance regulator (CFTR) is the main channel regulating fluid transport in this system, stimulated by phosphorylation by protein kinase A and inhibited by the AMP-activated protein kinase AMPK. During lumen expansion, CFTR remains open through the action of PHLPP1, which stops activated AMPK from inhibiting ion transport through CFTR. In the absence of PHLPP1, the restraint on AMPK activity is lost and this tips the balance in the favour of channel closing, resulting in the lack of lumen expansion and accumulation of mucus.

Indexed as

AMP-Activated Protein KinasesCystic Fibrosis Transmembrane Conductance RegulatorAnimalsDrosophila melanogasterHumansNuclear ProteinsPhosphoprotein PhosphatasesPhosphoric Monoester HydrolasesPhosphorylationAMP-Activated Protein KinasesCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorNuclear ProteinsPHLPP1 protein, humanPhosphoprotein PhosphatasesPhosphoric Monoester Hydrolases3D cultureAMPKCFTREpithelialLumenogenesisPHLPP

Identifiers

PMID35997536
PMCPMC9534488
OpenAlexW4292731324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.